186 related articles for article (PubMed ID: 32483207)
1. MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.
Tong D; Zhang J; Wang X; Li Q; Liu LY; Yang J; Guo B; Ni L; Zhao L; Huang C
Oncogenesis; 2020 Jun; 9(5):56. PubMed ID: 32483207
[TBL] [Abstract][Full Text] [Related]
2. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
3. p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin.
Jung JH; Lee H; Kim JH; Sim DY; Ahn H; Kim B; Chang S; Kim SH
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31022952
[TBL] [Abstract][Full Text] [Related]
4. Functional role of RRS1 in breast cancer cell proliferation.
Song J; Ma Z; Hua Y; Xu J; Li N; Ju C; Hou L
J Cell Mol Med; 2018 Dec; 22(12):6304-6313. PubMed ID: 30320499
[TBL] [Abstract][Full Text] [Related]
5. Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.
Cao B; Fang Z; Liao P; Zhou X; Xiong J; Zeng S; Lu H
Oncotarget; 2017 Oct; 8(53):90651-90661. PubMed ID: 29207594
[TBL] [Abstract][Full Text] [Related]
6. MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1.
Zhao LY; Tong DD; Xue M; Ma HL; Liu SY; Yang J; Liu YX; Guo B; Ni L; Liu LY; Qin YN; Wang LM; Zhao XG; Huang C
Oncogenesis; 2017 Jul; 6(7):e368. PubMed ID: 28759023
[TBL] [Abstract][Full Text] [Related]
7. MECP2 promotes the migration and invasion of gastric cancer cells by modulating the Notch1/c-Myc/mTOR signaling pathways by suppressing FBXW7 transcription.
Zhao L; Wang X; Yang J; Jiang Q; Zhang J; Wu F; Ni L; Tong D; Huang C
Am J Cancer Res; 2022; 12(11):5183-5204. PubMed ID: 36504898
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
[TBL] [Abstract][Full Text] [Related]
9. Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity.
Teng T; Mercer CA; Hexley P; Thomas G; Fumagalli S
Mol Cell Biol; 2013 Dec; 33(23):4660-71. PubMed ID: 24061479
[TBL] [Abstract][Full Text] [Related]
10. Olaparib Induces RPL5/RPL11-Dependent p53 Activation
Han T; Tong J; Wang M; Gan Y; Gao B; Chen J; Liu Y; Hao Q; Zhou X
Front Oncol; 2022; 12():821366. PubMed ID: 35719981
[TBL] [Abstract][Full Text] [Related]
11. The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.
Fancello L; Kampen KR; Hofman IJ; Verbeeck J; De Keersmaecker K
Oncotarget; 2017 Feb; 8(9):14462-14478. PubMed ID: 28147343
[TBL] [Abstract][Full Text] [Related]
12. Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia.
Cmejla R; Cmejlova J; Handrkova H; Petrak J; Petrtylova K; Mihal V; Stary J; Cerna Z; Jabali Y; Pospisilova D
Hum Mutat; 2009 Mar; 30(3):321-7. PubMed ID: 19191325
[TBL] [Abstract][Full Text] [Related]
13. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.
Zhou X; Hao Q; Liao J; Zhang Q; Lu H
Oncogene; 2013 Jan; 32(3):388-96. PubMed ID: 22391559
[TBL] [Abstract][Full Text] [Related]
14. MeCP2 inhibits proliferation and migration of breast cancer via suppression of epithelial-mesenchymal transition.
Jiang W; Liang YL; Liu Y; Chen YY; Yang ST; Li BR; Yu YX; Lyu Y; Wang R
J Cell Mol Med; 2020 Jul; 24(14):7959-7967. PubMed ID: 32510753
[TBL] [Abstract][Full Text] [Related]
15. MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/β-Catenin signaling pathway.
Zhang N; Wei ZL; Yin J; Zhang L; Wang J; Jin ZL
Am J Transl Res; 2018; 10(11):3542-3554. PubMed ID: 30662606
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.
Oršolić I; Bursać S; Jurada D; Drmić Hofman I; Dembić Z; Bartek J; Mihalek I; Volarević S
Oncogene; 2020 Apr; 39(17):3443-3457. PubMed ID: 32108164
[TBL] [Abstract][Full Text] [Related]
17. RPL32 Promotes Lung Cancer Progression by Facilitating p53 Degradation.
Xie J; Zhang W; Liang X; Shuai C; Zhou Y; Pan H; Yang Y; Han W
Mol Ther Nucleic Acids; 2020 Sep; 21():75-85. PubMed ID: 32516735
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11.
Park J; Cho M; Cho J; Kim EE; Song EJ
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205710
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells.
Qin Y; Zhao L; Wang X; Tong D; Hoover C; Wu F; Liu Y; Wang L; Liu L; Ni L; Song T; Huang C
Glycobiology; 2017 Apr; 27(4):306-317. PubMed ID: 28100567
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 Promotes Colorectal Cancer Metastasis by Modulating ZEB1 Transcription.
Luo D; Ge W
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32210086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
